We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Seeks to Discontinue Drug Sales of Pharmaceuticals International
EMA Seeks to Discontinue Drug Sales of Pharmaceuticals International
The EMA has recommended that three medicines manufactured by Pharmaceuticals International no longer be available in the EU due to possible cross-contamination.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor